Myelodysplastic Syndrome Clinical Trial

Physical Activity in Transfusion Dependent Patients With Myelodysplastic Syndrome

Summary

This study assesses feasibility and patient acceptability of using a Fitbit to monitor step count and heart rate in transfusion dependent patients with myelodysplastic syndrome. Information from this study may help researchers understand if there is any correlation between activity level and anemia.

View Full Description

Full Description

This study assesses feasibility and patient acceptability of using a Fitbit to monitor step count and heart rate in transfusion dependent patients with myelodysplastic syndrome. Information from this study may help researchers understand if there is any correlation between activity level and anemia.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Confirmed pathologic diagnosis of MDS
Requiring >= 2 blood transfusions in the past month if previously diagnosed or hemoglobin =< 8 g/dL if newly diagnosed
Age >= 18
Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2
Ambulatory (use of a walking aid, such as a cane or rollator, is acceptable)
Able to give informed consent
Willing to comply with all study procedures and available for the duration of the study
Able to read and/or understand English
Have access to an iPhone 4S or later, iPad 3 generation or later, Android 5.0 or later, or Windows 10 device
Have access to Bluetooth low energy (LE) and internet connection for syncing

Exclusion Criteria:

• Uncontrolled illness including, but not limited to, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements

Study is for people with:

Myelodysplastic Syndrome

Study ID:

NCT04969367

Recruitment Status:

Withdrawn

Sponsor:

Thomas Jefferson University

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Sidney Kimmel Cancer Center at Thomas Jefferson University
Philadelphia Pennsylvania, 19107, United States

How clear is this clinincal trial information?

Study is for people with:

Myelodysplastic Syndrome

Study ID:

NCT04969367

Recruitment Status:

Withdrawn

Sponsor:


Thomas Jefferson University

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.